IDDST-2022
Scientific Program

Day 1 | Day 2 | Day 3

 

Keynote Forum

Day 1: Morning, May 11, 2022

Moderator

Call for Moderator

Time

Speeches and Speakers

09:00-09:05

Chair's Introduction

09:05-09:30

Title: TBD

Dr. H. Michael Shepard, President and CEO, Enosi Life Sciences, USA

2019 Lasker Awards

09:30-09:55

Title: How Spearheading Cell & Gene Therapy Changes Our Innovation Model in Pharma

Dr. Wolfram Carius, Executive Vice President of Cell and Gene Therapy, Pharmaceuticals Division, Bayer Pharmaceuticals, Germany

09:55-10:20

Title: Cell-penetrating Peptides and Drug Delivery

Dr. Ulo Langel, Professor, Stockholm University, Sweden

Member of the Academia Europaea; Foreign Member of Estonian Academy of Science

10:20-10:45

Title: Genomes, Structural Biology and Drug Discovery: Combating the Impacts of Mutations in Genetic Disease and Antibiotic Resistance

Dr. Tom Blundell, Professor, Department of Biochemistry, University of Cambridge, UK

Member of Academia Europaea; Fellow of the Royal Society; Fellow of Academy of Medical Sciences

10:45-11:10

Speech Opportunity Available

11:10-11:35

Speech Opportunity Available

 

Session 211: Pharmacogenetics, Pharmacogenomics and Precision Medicine 

Day 1: Afternoon, May 11, 2022

Chair

Dr. Chuang Kee Ong, Associate Director, Centre of Genomics Research, Precision Medicine and Genomics, AstraZeneca UK Limited, UK

Co-Chair

Dr. Fan-Gang Tseng, Distinguished Professor and Vice President for Research and Development, National Tsing Hua University Taiwan,Taiwan (China)

Time

Speeches and Speakers

13:30-13:35

Chair's Introduction

13:35-13:55

Keynote Speech Title: Predictive, Preventive and Personalized Medicine (PPPM) as a Strategic Avenue and Global Tool for Advancing T1D-related Care

Dr. Sergey Suchkov, Professor, Department of Clinical Allergology & Immunology, A.I.Evdokimov Moscow State University of Medicine & Dentistry, Russia

13:55-14:15

Title: Beyond Cancer and Rare Disease: Extending Precision Medicine into Chronic Diseases

Dr. Steve Gardner, CEO, PrecisionLife Ltd, UK

14:15-14:35

Title: AstraZeneca’s 2 Millions Genomes Initiative and the relevance of FAIR Data Principles in Pharmaceutical R&D

Dr. Chuang Kee Ong, Associate Director, Centre of Genomics Research, Precision Medicine and Genomics, AstraZeneca UK Limited, UK

14:35-14:55

Title: TBD

Dr. Michelle Chen, Vice President, Head of Corporate Development, WuXi Biologics, USA

14:55-15:15

Title: Automatic SACA System for Single Circulating Tumor Cells/Microembolis (CTCs/CTMs) Rapid Diagnosis/Prognosis

Dr. Fan-Gang Tseng, Distinguished Professor, National Tsing Hua University Taiwan,Taiwan (China)

15:20-15:30

Coffee Break

15:30-15:50

Title: TBD

Dr. Concetta Ambrosino, Associate Professor, UNIVERSITÀ DEGLI STUDI DEL SANNIO, Italy

15:50-16:10

Title: Methods of Screening Diagnostics of Human Health Using the IT-technologies

Dr. Aizman Roman, Professor, Novosibirsk State Pedagogical University, Russia

16:10-16:30

Title: Aberrant RNA Metabolism in Amyotrophic Lateral Sclerosis (ALS) Caused by Mutations in C9ORF72 Gene

Dr. Hitomi Tsuiji, Senior Lecturer, Department of Biomedical Science, Graduate School of Pharmaceutical Sciences, Nagoya City University, Japan

16:30-16:50

Title: The Precision Medicine of Infertility

Dr. Chiungfang Peng, President & CEO, FUGA Biotechnology Co, Ltd., Taiwan (China)

16:50-17:10

Speech Opportunity Available

 

Session 221: Innovative Drug Discovery Technology

Day 1: Afternoon, May 11, 2022

Chair

Dr. Richard Denk, Senior Consultant, Aseptic Processing & Containment, SKAN AG, Switzerland

Time

Speeches and Speakers

13:30-13:35

Chair's Introduction

13:35-13:55

Title: New Insights into the Use of Hydroxypropyl Cellulose for Drug Solubility Enhancement
Dr. Edmont Stoyanov, Technical Director, Nisso Chemical Europe GmbH, Germany

13:55-14:15

Title: GMP and Occupational Safety for the Commercial Manufacturing of Gene and Cell Therapies

Dr. Richard Denk, Senior Consultant, Aseptic Processing & Containment, SKAN AG, Switzerland

14:15-14:35

Title: Mimotope a New Method to Develop Vaccines Stable at 4°C

Dr. Erwann P. Loret, Aix Marseille University, France

14:35-14:55

Speech Opportunity Available

  14:55-15:15

Title: Cell Culture Based Biologics Production in Serum/Animal Protein-free Conditions
Dr. S. Ismet Deliloglu-Gurhan, Professor, Research and Application Center of Drug Development and Pharmacokinetics (ARGEFAR), Ege University, Turkey

15:15-15:30

Coffee Break

 

Session 311: Cancer Drug Targets  

Day 1: Afternoon, May 11, 2022

Chair

Dr. Anna Juncker-Jensen, Principal Scientist, NeoGenomics Laboratories, Inc., USA

Co-Chair

Dr. Xiaoyan Jiang, Professor, University of British Columbia, Canada

Time

Speeches and Speakers

13:30-13:35

Chair's Introduction

13:35-13:55

Title: Oxidized Macrophage Migration Inhibitory Factor (oxMIF) – an Unrecognized Target for Cancer Therapeutics

Dr. Randolf Kerschbaumer, Managing Director & CEO, OncoOne Research & Development GmbH, Austria

13:55-14:15

Title: TBD

Dr. Anna Juncker-Jensen, Principal Scientist, NeoGenomics Laboratories, Inc., USA

14:15-14:35

Title: Drug Targeting Approaches against KRAS Surrogate Targets

Dr. Daniel Abankwa, Professor, Department of Life Sciences and Medicine, University of Luxembourg, Luxembourg

14:35-14:55

Title: TBD

Dr. Mohan Natarajan, Professor, Department of Pathology & Integrative Physiology School of Medicine, University of Texas Health Sciences Center, USA

14:55-15:15

Title: TBD

Dr. Xiaoyan Jiang, Professor, University of British Columbia, Canada

15:15-15:30

Coffee Break

15:30-15:50

Title: The Construction of Structurally Diverse Covalent Inhibitor Library and Their Application in Drug Discovery for Rare Cancer

Dr. Shunying Liu, Professor, Shanghai Engineering Research Center of Molecular Therapeutics and New Drug Development, School of Chemistry and Chemical Engineering, East China Normal University, China

15:50-16:10

Title: Therapy-driven Molecular Evolution and Its Implications for Predicting Drug Response in Glioblastoma

Dr. Ella L Kim, Department of Neurosurgery, Johannes Gutenberg University Medical Centre, Germany

16:10-16:30

Speech Opportunity Available

16:30-16:50

Title: Neuroendocrine Differentiation in Prostate Cancer

Dr. Luca Puccetti, Division of Urology, San Lazzaro Hospital, Italy

16:50-17:10

Title: The E3 Ubiquitin-ligase Hakai as a Novel Therapeutic Strategy against Cancer

Dr. Angelica Figueroa, Research Group Leader, Institute for Biomedical Research of A Coruna (INIBIC), Spain

 

Session 321: Open Innovation in Drug Discovery

Day 1: Afternoon, May 11, 2022

Chair

Dr. Wolfgang Fecke, Director General, EU-OPENSCREEN, Germany

Time

Speeches and Speakers

13:30-13:35

Chair's Introduction

13:35-13:55

Title: How LEO Pharma Advances Innovation in Medical Dermatology through Partnerships around the World

Dr. Hitoshi Shiota, Scientist, LEO Science & Tech Hub Tokyo, Japan

13:55-14:15

Title: Access to the European Infrastructure for Chemical Biology EU-OPENSCREEN

Dr. Wolfgang Fecke, Director General, EU-OPENSCREEN, Germany

14:15-14:35

Speech Opportunity Available

14:35-14:55

Title: The National Institute of Health Research Nottingham Biomedical Research Centre as a Framework for Partnership to Drive Drug Discovery

Dr. Maria Koufali, Managing Director, Research and Innovation, Nottingham University Hospitals NHS Trust, UK

14:55-15:15

Title: Ketamine/Propofol Admixture (“KETOFOL”) for Sedation: The Real Deal or Not?

Dr. Nathan J Smischney, Associate Professor, Department of Anesthesiology, Mayo Clinic, USA

15:15-15:30

Coffee Break

 

Session 411: Cancers/Tumors

Day 1: Afternoon, May 11, 2022

Chair

Dr. Yan Leyfman, Professor, Penn State College of Medicine, USA

 Co-Chair

Dr. Kiyoshi Eshima, President, Department of Oncology Research and Development, Delta-Fly Pharm, Inc, Japan

Time

Speeches and Speakers

13:30-13:35

Chair's Introduction

13:35-13:55

Speech Opportunity Available

13:55-14:15

Speech Opportunity Available

14:15-14:35

Title: Emerging Approaches and Techniques in the Management of Aneurysmal Bone Cysts

Dr. Gennady N Machak, Priorov Central Institute for Traumatology and Orthopedics, Russia

  14:35-14:55

Title: Thermal IR Imaging of Tumors and Inner Cancerous Anomalies Injected in Mice for Temperature Contrast Assessment – Experimental Results

Dr. Nathan Blaunstein, Professor-Emeritus, Ben Gurion University of the Negev, Israel

  14:55-15:15

Title: Primary Endpoints in Interventional Oncology Clinical Trials: towards a Consensus Paper

Dr. Lucio Fumi, CEO, Wyfold Medical, UK

15:15-15:35

Title: Robotic Surgery in Oncologic Urology

Dr. Anton Ponholzer, Guest Professor, Medical University of Vienna, Austria

15:35-15:50

Coffee Break

15:50-16:10

Title: Module Technology for Cancer Chemotherapy

Dr. Kiyoshi Eshima, President, Department of Oncology Research and Development, Delta-Fly Pharm, Inc, Japan

16:10-16:30

Title: Off Label Medication in Obstetrics

Dr. Ioana-Claudia Lakovschek, Department of Obstetrics and Gynecology, Medical University of Graz, Austria

16:30-16:50

Title: Controversies, Consensus and Collaboration in the Use of I-131 Therapy in Differentiated Thyroid Cancer

Dr. Ciprian Draganescu, Head of Nuclear Medicine Department, University Hospital of Martinique, Martinique

16:50-17:10

Title: Colorectal Cancer Stem Cell Vaccine with High Expression of MUC1 Serves as a Novel Prophylactic Vaccine for Colorectal Cancer

Dr. Jun Dou, Reseacher, Southeast University, China

17:10-17:30

Title: Can Physical Activity Enhance Breast Cancer Suvivors' Sleep

Dr. Hongchang Yang, Hohai University, China

 

Session 421: Recent Advances in Immunotherapy

Day 1: Afternoon, May 11, 2022

Chair

Dr. Milosevic Slavoljub, Vice President, Medigene AG, Germany

 Co-Chair

Dr. Melita Irving, Group Leader, Department of Oncology Ludwig Institute for Cancer Research, University of Lausanne, Switzerland

Time

 

13:30-13:35

Chair's Introduction

13:35-14:00

Title: Th1-epitope Peptide is Critical for Potentiating Therapeutic Efficacy of Cancer in H/K-HELP Vaccine Therapy and DC-based Vaccine Cell Therapy

Dr. Takashi Nishimura, Director, NPO Immuno support Center, Japan

14:00-14:25

Title: Identifying Functional Neo-antigens by HTS

Dr. Milosevic Slavoljub, Vice President, Medigene AG, Germany

14:25-14:50

Title: Expression Data Integration: Advancing Immuno-oncology Target Discovery

Dr. Frank Staubli, Nebion AG, Switzerland

14:50-15:15

Title: Marked Global DNA Hypomethylation Is Associated with Constitutive PD-L1 Expression in Melanoma

Dr. Mike Eccles, Professor, New Zealand Institute for Cancer Research Trust, New Zealand

15:15-15:30

Coffee Break

15:30-15:55

Title: Immunotherapy for Gastric Cancer by Targeting a Specific Chemokine

Dr. Wei-Qiang Gao, "KC Wong" Endowed Chair Professor, Dean of Med-X Research Institute, Director of Renji Hospital Stem Cell Research Center, Shanghai Jiao Tong University, China

15:55-16:20

Title: Next Generation T-cell Engineering Strategies Against Solid Tumors
Dr. Melita Irving, Group Leader, Department of Oncology Ludwig Institute for Cancer Research, University of Lausanne, Switzerland

16:20-16:45

Speech Opportunity Available

16:45-17:10

Title: How can Drug Delivery Approaches Enhance Immunotherapy?

Dr. Sifei Han, NHMRC Early Career Fellow, Drug Delivery, Disposition and Dynamics, Monash Institute of Pharmaceutical Sciences, Monash University (Parkville Campus), Australia

 

Session 431: Natural Product Discovery

Day 1: Afternoon, May 11, 2022

Chair

Dr. Dulcie A Mulholland, Professor, Department of Chemistry, University of Surrey, UK

Co-Chair   Dr. Chen Situ, Lecturer, School of Biological Sciences, Queen’s University Belfast, UK

Time

 

13:30-13:35

Chair's Introduction

13:35-14:00

Title: Monoterpens as New Biologics and Geroprotectors

Dr. Patrizia A. d'Alessio, CEO, AISA Therapeutics & Head of ISOAD France, France

14:00-14:25

Title: The Use of Homoisoflavonoids in the Treatment of Retinopathy

Dr. Dulcie A Mulholland, Professor, Department of Chemistry, University of Surrey, UK

14:25-14:50

Title: The Benefit of Plant Natural Compounds Affecting the Arachidonic Acid Pathway

Dr. Lenka Langhansova, Associate Researcher, The Institute of Experimental Botany, The Czech Academy of Sciences (CAS), Czech Republic

14:50-15:15

Title: Poly(Sugar Acids): Novel Acidic Polysaccharide Poly[3-(3,4-Dihydroxyphenyl)Glyceric Acid] from Medicinal Plants of Boraginaceae Family its Synthetic Analogues and Their Anticancer Efficaccy

Dr. Vakhtang Barbakadze, Head of Department of Plant Biopolymers, Kutateladze Institute of Pharmacochemistry, Tbilisi State Medical University, Georgia

15:15-15:30

Coffee Break

15:30-15:55

Title: How can Commercially Available Enzymes Contribute to the Discovery of New Nutraceuticals?

Dr. Lutz Fischer, Professor, Department of Biotechnology and Enzyme Science, Institute of Food Science and Biotechnology, University of Hohenheim, Germany

15:55-16:20

Speech Opportunity Available

16:20-16:45

Title: Biological Activity and Pharmacological Properties of Polynesian Calophyllum Inophyllum Oil Extracts

Dr. Phila Raharivelomanana, Professor, University of French Polyneisa, FRENCH POLYNESIA
 

16:45-17:10

Title: Antibacterial Multitarget Properties of Medicinal Plants

Dr. Chen Situ, Lecturer, School of Biological Sciences, Queen’s University Belfast, UK

 

Stream 5: Young Scientist Forum

Day 1: Afternoon, May 11, 2022

Chair

Call for Chair

Time

 

13:30-13:35

Chair's Introduction

13:35-14:00

Title: Image-based Powder Flow Characterization: An Additional Tool for Process Optimization in the Pharmaceutical Industry

Mr. David Blanco, Division of Pharmaceutical Chemistry and Technology, Faculty of Pharmacy, University of Helsinki, Finland

14:00-14:25

Speech Opportunity Available

14:25-14:50

Title: Cancer Risk after Cardiac Catheterization in Childhood

Mr. Kossi D Abalo, Laboratory of Epidemiology, Institute for Radiological Protection and Nuclear Safety, France

14:50-15:15

Title: Accelerating Recruitment of Alzheimer's Disease Clinical Trials through Open Access Memory Testing

Mr. Daniel Wojcik, Medical University of Lodz, Poland

15:15-15:30

Coffee Break

 

 

 

 



© 2003-2022 All rights reserved by BIT Congress
Contact Us: Tel:0086-411-84799609,Email:Irene@iddst.com